The other 10 advanced GIST patients received surgery and imatinib mesylate therapy, and the clinical benefit rate of imatinib mesylate was 75%.

• 其余10例晚期患者接受手术和甲磺酸伊马替尼治疗，甲磺酸伊马替尼的临床获益率75%25。